SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5kca'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BSX_A_T3A1_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 690 ILE A 694 LEU A 713 ILE A 655 PHE A 698	None	1.01A	1bsxA-5kcaA: undetectable	1bsxA-5kcaA: 15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BSX_B_T3B2_1 (PROTEIN (THYROID HORMONE RECEPTOR BETA))	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 690 ILE A 694 LEU A 713 ILE A 655 PHE A 698	None	1.01A	1bsxB-5kcaA: undetectable	1bsxB-5kcaA: 15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD507_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 7	PHE A 258 ALA A 283 ILE A 226 ILE A 269	None	0.99A	1oniD-5kcaA: undetectable 1oniF-5kcaA: undetectable	1oniD-5kcaA: 11.13 1oniF-5kcaA: 11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD507_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 7	PHE A 400 ALA A 425 ILE A 368 ILE A 411	None	0.99A	1oniD-5kcaA: undetectable 1oniF-5kcaA: undetectable	1oniD-5kcaA: 11.13 1oniF-5kcaA: 11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XZX_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA-1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 747 ILE A 717 LEU A 671 ILE A 664 PHE A 654	None	1.14A	1xzxX-5kcaA: undetectable	1xzxX-5kcaA: 15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BNN_B_FCNB1199_1 (EPOXIDASE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	LEU A 839 GLU A 215 HIS A 834 ALA A 837	None	0.96A	2bnnA-5kcaA: 2.2 2bnnB-5kcaA: undetectable	2bnnA-5kcaA: 12.27 2bnnB-5kcaA: 12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H79_A_T3A1_1 (THRA PROTEIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 690 ILE A 694 LEU A 713 ILE A 655 PHE A 698	None	1.10A	2h79A-5kcaA: undetectable	2h79A-5kcaA: 14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEI_A_CXXA802_1 (TRANSPORTER)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	ARG A 715 PHE A 654 ILE A 717 PHE A 670	None	0.98A	2qeiA-5kcaA: undetectable	2qeiA-5kcaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEK_A_DIFA1373_1 (ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	SER A 140 PHE A 142 VAL A 261 ASN A 213	None	1.01A	2wekA-5kcaA: 3.5	2wekA-5kcaA: 17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEK_B_DIFB1373_1 (ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	SER A 140 PHE A 142 VAL A 261 ASN A 213	None	1.03A	2wekB-5kcaA: 3.6	2wekB-5kcaA: 17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ALA A 564 LEU A 591 LEU A 594 ILE A 576 GLY A 516	None	1.20A	2yjaB-5kcaA: undetectable	2yjaB-5kcaA: 15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GWS_X_T3X500_1 (THYROID HORMONE RECEPTOR BETA)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 690 ILE A 694 LEU A 713 ILE A 655 PHE A 698	None	1.04A	3gwsX-5kcaA: undetectable	3gwsX-5kcaA: 15.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IW1_A_ASDA1223_1 (CYTOCHROME P450 CYP125)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 791 VAL A 817 PHE A 530 VAL A 529 ILE A 605	None	1.17A	3iw1A-5kcaA: undetectable	3iw1A-5kcaA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_K_TFPK202_1 (PROTEIN S100-A4)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	LEU A 415 PHE A 398 ILE A 443 PHE A 64 SER A 154	None	1.22A	3ko0K-5kcaA: undetectable 3ko0L-5kcaA: undetectable 3ko0S-5kcaA: undetectable 3ko0T-5kcaA: undetectable	3ko0K-5kcaA: 7.91 3ko0L-5kcaA: 7.91 3ko0S-5kcaA: 7.91 3ko0T-5kcaA: 7.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KO0_S_TFPS202_1 (PROTEIN S100-A4)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	LEU A 415 PHE A 398 ILE A 443 PHE A 64	None	1.02A	3ko0S-5kcaA: undetectable	3ko0S-5kcaA: 7.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MEK_A_SAMA510_0 (SET AND MYND DOMAIN-CONTAINING PROTEIN 3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.18A	3mekA-5kcaA: undetectable	3mekA-5kcaA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MG0_2_BO221405_1 (PROTEASOME COMPONENT PRE3 PROTEASOME COMPONENT PUP1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	THR A 184 ALA A 141 GLY A 440 HIS A 259 SER A 296	None	1.17A	3mg02-5kcaA: undetectable 3mg0V-5kcaA: undetectable	3mg02-5kcaA: 14.68 3mg0V-5kcaA: 15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PS9_A_SAMA670_1 (TRNA 5-METHYLAMINOMETHYL- 2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	GLY A 144 THR A 126 GLU A 151 ASP A 147	None	1.04A	3ps9A-5kcaA: 3.1	3ps9A-5kcaA: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QWP_A_SAMA510_0 (SET AND MYND DOMAIN-CONTAINING PROTEIN 3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.19A	3qwpA-5kcaA: undetectable	3qwpA-5kcaA: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SOA_A_DB8A445_1 (CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA WITH A BETA 7 LINKER)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	LEU A 671 VAL A 674 MET A 679 PHE A 654	None	1.04A	3soaA-5kcaA: undetectable	3soaA-5kcaA: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U7S_A_017A202_1 (POL POLYPROTEIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 9	LEU A 820 ALA A 533 ASP A 536 ILE A 791 LEU A 819	None	0.99A	3u7sA-5kcaA: undetectable	3u7sA-5kcaA: 9.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UVV_A_T3A501_1 (THYROID HORMONE RECEPTOR ALPHA)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ILE A 747 ILE A 717 LEU A 671 ILE A 664 PHE A 654	None	1.08A	3uvvA-5kcaA: undetectable	3uvvA-5kcaA: 15.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AWU_A_4CHA502_0 (OXIDOREDUCTASE, FMN-BINDING)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 7	THR A 103 ASN A 134 LEU A 133 PHE A 185	None	1.38A	4awuA-5kcaA: undetectable	4awuA-5kcaA: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AWU_A_4CHA502_0 (OXIDOREDUCTASE, FMN-BINDING)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 7	THR A 245 ASN A 276 LEU A 275 PHE A 327	None	1.37A	4awuA-5kcaA: undetectable	4awuA-5kcaA: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DRJ_A_RAPA201_2 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4 SERINE/THREONINE-PRO TEIN KINASE MTOR)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	SER A 186 PHE A 185 THR A 103 PHE A 188	None	1.02A	4drjB-5kcaA: undetectable	4drjB-5kcaA: 8.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DRJ_A_RAPA201_2 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4 SERINE/THREONINE-PRO TEIN KINASE MTOR)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	SER A 328 PHE A 327 THR A 245 PHE A 330	None	1.03A	4drjB-5kcaA: undetectable	4drjB-5kcaA: 8.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DRJ_A_RAPA201_2 (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4 SERINE/THREONINE-PRO TEIN KINASE MTOR)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	SER A 470 PHE A 469 THR A 387 PHE A 472	None	1.06A	4drjB-5kcaA: undetectable	4drjB-5kcaA: 8.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	PHE A 114 ALA A 167 ALA A 106 PRO A 107	None	1.04A	4dtzB-5kcaA: undetectable	4dtzB-5kcaA: 18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	PHE A 256 ALA A 309 ALA A 248 PRO A 249	None	1.05A	4dtzB-5kcaA: undetectable	4dtzB-5kcaA: 18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ENH_A_FVXA602_1 (CHOLESTEROL 24-HYDROXYLASE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	LEU A 455 ILE A 368 ILE A 411 ALA A 427 GLY A 440	None	1.10A	4enhA-5kcaA: undetectable	4enhA-5kcaA: 18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FEX_B_KANB301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 7	ASP A 289 ASP A 287 GLU A 151 ASP A 431	None	1.19A	4fexB-5kcaA: undetectable	4fexB-5kcaA: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKH_B_KANB301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	ASP A 289 ASP A 287 GLU A 151 ASP A 431	None	1.17A	4gkhB-5kcaA: undetectable	4gkhB-5kcaA: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GKI_C_KANC301_1 (AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERAS E APHA1-IAB)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	ASP A 289 ASP A 287 GLU A 151 ASP A 431	None	1.20A	4gkiC-5kcaA: undetectable	4gkiC-5kcaA: 15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_C_ADNC401_2 (ADENOSINE KINASE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 5	ASN A 822 LEU A 819 SER A 865 ASN A 881	None	1.30A	4n09C-5kcaA: undetectable	4n09C-5kcaA: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4POO_B_SAMB301_0 (PUTATIVE RNA METHYLASE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	THR A 629 GLY A 877 ASN A 876 HIS A 602 SER A 581	None	1.22A	4pooB-5kcaA: 2.7	4pooB-5kcaA: 14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 259 SER A 296 THR A 184 ALA A 141 GLY A 440	None	1.19A	4qvnV-5kcaA: undetectable 4qvnb-5kcaA: undetectable	4qvnV-5kcaA: 14.24 4qvnb-5kcaA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 401 SER A 438 THR A 326 ALA A 283 GLY A 156	None	1.16A	4qvnV-5kcaA: undetectable 4qvnb-5kcaA: undetectable	4qvnV-5kcaA: 14.24 4qvnb-5kcaA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 259 SER A 296 THR A 184 ALA A 141 GLY A 440	None	1.18A	4qvnH-5kcaA: undetectable 4qvnN-5kcaA: undetectable	4qvnH-5kcaA: 14.24 4qvnN-5kcaA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 401 SER A 438 THR A 326 ALA A 283 GLY A 156	None	1.15A	4qvnH-5kcaA: undetectable 4qvnN-5kcaA: undetectable	4qvnH-5kcaA: 14.24 4qvnN-5kcaA: 14.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XJE_A_TOYA202_1 (AADB)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	ASP A 145 GLU A 547 ILE A 512 TYR A 324	None	1.03A	4xjeA-5kcaA: undetectable	4xjeA-5kcaA: 11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AXD_A_RBVA502_2 (ADENOSYLHOMOCYSTEINA SE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	3 / 3	THR A 212 HIS A 599 LEU A 839	None	0.57A	5axdA-5kcaA: 4.1	5axdA-5kcaA: 18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CCM_A_SAMA504_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.22A	5ccmA-5kcaA: undetectable	5ccmA-5kcaA: 18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CFS_A_TOYA203_1 (AAD(2''),GENTAMICIN 2''-NUCLEOTIDYLTRANS FERASE,GENTAMICIN RESISTANCE PROTEIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 8	ASP A 145 GLU A 547 ILE A 512 TYR A 324	None	0.96A	5cfsA-5kcaA: undetectable	5cfsA-5kcaA: 11.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FQD_E_LVYE1438_1 (PROTEIN CEREBLON CASEIN KINASE I ISOFORM ALPHA)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ASN A 115 HIS A 117 SER A 183 PHE A 86 ILE A 139	None	1.43A	5fqdE-5kcaA: undetectable 5fqdF-5kcaA: undetectable	5fqdE-5kcaA: 18.16 5fqdF-5kcaA: 16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NFP_A_8W5A804_2 (GLUCOCORTICOID RECEPTOR)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 4	LEU A 630 MET A 855 ILE A 605 LEU A 820	None	1.41A	5nfpA-5kcaA: undetectable	5nfpA-5kcaA: 14.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5PBE_A_TYLA2001_1 (BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	VAL A 261 TYR A 324 ASN A 213 ILE A 512	None	0.93A	5pbeA-5kcaA: undetectable	5pbeA-5kcaA: 9.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UPD_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 11	ARG A 786 GLY A 787 ASN A 540 TYR A 814 LEU A 818	None	1.44A	5updA-5kcaA: undetectable	5updA-5kcaA: 12.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V37_A_SAMA504_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.43A	5v37A-5kcaA: undetectable	5v37A-5kcaA: 18.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_A_PCFA1801_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	ILE A 745 ILE A 664 LEU A 671 PHE A 670	None	1.00A	5vkqA-5kcaA: undetectable 5vkqB-5kcaA: undetectable	5vkqA-5kcaA: 19.13 5vkqB-5kcaA: 19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VKQ_D_PCFD1807_0 (NO MECHANORECEPTOR POTENTIAL C ISOFORM L)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	ILE A 745 ILE A 664 LEU A 671 PHE A 670	None	0.98A	5vkqA-5kcaA: undetectable 5vkqD-5kcaA: undetectable	5vkqA-5kcaA: 19.13 5vkqD-5kcaA: 19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXG_A_SAMA502_0 (SMYD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.30A	5xxgA-5kcaA: undetectable	5xxgA-5kcaA: 18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXJ_A_SAMA505_0 (SMYD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	ARG A 786 GLY A 787 ASN A 788 ASN A 822 TYR A 814	None	1.20A	5xxjA-5kcaA: undetectable	5xxjA-5kcaA: 18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CEN_A_SAMA1301_0 (HISTONE-LYSINE N-METHYLTRANSFERASE NSD3)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 11	ARG A 786 GLY A 787 ASN A 540 TYR A 814 LEU A 818	None	1.39A	6cenA-5kcaA: undetectable	6cenA-5kcaA: 12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CK2_C_IPHC101_0 (INSULIN A CHAIN INSULIN B CHAIN)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 4	ILE A 813 LEU A 820 HIS A 602 ALA A 578	None	0.86A	6ck2C-5kcaA: undetectable 6ck2D-5kcaA: undetectable	6ck2C-5kcaA: 2.58 6ck2D-5kcaA: 3.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EF6_A_ACTA405_0 (AMINOGLYCOSIDE PHOSPHOTRANSFERASE)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	4 / 6	PRO A 777 GLN A 782 ARG A 783 ILE A 780	None	1.46A	6ef6A-5kcaA: undetectable	6ef6A-5kcaA: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_B_BO2B201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 259 SER A 296 THR A 184 ALA A 141 GLY A 440	None	1.22A	6hwdV-5kcaA: undetectable 6hwdb-5kcaA: undetectable	6hwdV-5kcaA: 9.55 6hwdb-5kcaA: 6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_B_BO2B201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 401 SER A 438 THR A 326 ALA A 283 GLY A 156	None	1.19A	6hwdV-5kcaA: undetectable 6hwdb-5kcaA: undetectable	6hwdV-5kcaA: 9.55 6hwdb-5kcaA: 6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_N_BO2N201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 259 SER A 296 THR A 184 ALA A 141 GLY A 440	None	1.23A	6hwdH-5kcaA: undetectable 6hwdN-5kcaA: undetectable	6hwdH-5kcaA: 9.55 6hwdN-5kcaA: 6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_N_BO2N201_0 (PROTEASOME SUBUNIT BETA TYPE-1 PROTEASOME SUBUNIT BETA TYPE-2)	5kca	CEREBELLIN-1,CEREBEL LIN-1,CEREBELLIN-1,G LUTAMATE RECEPTOR IONOTROPIC, DELTA-2 (Homo sapiens)	5 / 12	HIS A 401 SER A 438 THR A 326 ALA A 283 GLY A 156	None	1.20A	6hwdH-5kcaA: undetectable 6hwdN-5kcaA: undetectable	6hwdH-5kcaA: 9.55 6hwdN-5kcaA: 6.91

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BSX_A_T3A1_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 690;ILE A 694;LEU A 713;ILE A 655;PHE A 698","None","1.01A","1bsxA-5kcaA:undetectable","1bsxA-5kcaA:15.07"],["1BSX_B_T3B2_1","PROTEIN (THYROID HORMONE RECEPTOR BETA)","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 690;ILE A 694;LEU A 713;ILE A 655;PHE A 698","None","1.01A","1bsxB-5kcaA:undetectable","1bsxB-5kcaA:15.07"],["1ONI_D_BEZD507_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"PHE A 258;ALA A 283;ILE A 226;ILE A 269","None","0.99A","1oniD-5kcaA:undetectable;1oniF-5kcaA:undetectable","1oniD-5kcaA:11.13;1oniF-5kcaA:11.13"],["1ONI_D_BEZD507_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"PHE A 400;ALA A 425;ILE A 368;ILE A 411","None","0.99A","1oniD-5kcaA:undetectable;1oniF-5kcaA:undetectable","1oniD-5kcaA:11.13;1oniF-5kcaA:11.13"],["1XZX_X_T3X500_1","THYROID HORMONE RECEPTOR BETA-1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 747;ILE A 717;LEU A 671;ILE A 664;PHE A 654","None","1.14A","1xzxX-5kcaA:undetectable","1xzxX-5kcaA:15.48"],["2BNN_B_FCNB1199_1","EPOXIDASE;EPOXIDASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"LEU A 839;GLU A 215;HIS A 834;ALA A 837","None","0.96A","2bnnA-5kcaA:2.2;2bnnB-5kcaA:undetectable","2bnnA-5kcaA:12.27;2bnnB-5kcaA:12.27"],["2H79_A_T3A1_1","THRA PROTEIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 690;ILE A 694;LEU A 713;ILE A 655;PHE A 698","None","1.10A","2h79A-5kcaA:undetectable","2h79A-5kcaA:14.40"],["2QEI_A_CXXA802_1","TRANSPORTER","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ARG A 715;PHE A 654;ILE A 717;PHE A 670","None","0.98A","2qeiA-5kcaA:undetectable","2qeiA-5kcaA:20.20"],["2WEK_A_DIFA1373_1","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"SER A 140;PHE A 142;VAL A 261;ASN A 213","None","1.01A","2wekA-5kcaA:3.5","2wekA-5kcaA:17.90"],["2WEK_B_DIFB1373_1","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"SER A 140;PHE A 142;VAL A 261;ASN A 213","None","1.03A","2wekB-5kcaA:3.6","2wekB-5kcaA:17.90"],["2YJA_B_ESTB1550_1","ESTROGEN RECEPTOR","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ALA A 564;LEU A 591;LEU A 594;ILE A 576;GLY A 516","None","1.20A","2yjaB-5kcaA:undetectable","2yjaB-5kcaA:15.77"],["3GWS_X_T3X500_1","THYROID HORMONE RECEPTOR BETA","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 690;ILE A 694;LEU A 713;ILE A 655;PHE A 698","None","1.04A","3gwsX-5kcaA:undetectable","3gwsX-5kcaA:15.53"],["3IW1_A_ASDA1223_1","CYTOCHROME P450 CYP125","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 791;VAL A 817;PHE A 530;VAL A 529;ILE A 605","None","1.17A","3iw1A-5kcaA:undetectable","3iw1A-5kcaA:19.51"],["3KO0_K_TFPK202_1","PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"LEU A 415;PHE A 398;ILE A 443;PHE A  64;SER A 154","None","1.22A","3ko0K-5kcaA:undetectable;3ko0L-5kcaA:undetectable;3ko0S-5kcaA:undetectable;3ko0T-5kcaA:undetectable","3ko0K-5kcaA:7.91;3ko0L-5kcaA:7.91;3ko0S-5kcaA:7.91;3ko0T-5kcaA:7.91"],["3KO0_S_TFPS202_1","PROTEIN S100-A4","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"LEU A 415;PHE A 398;ILE A 443;PHE A  64","None","1.02A","3ko0S-5kcaA:undetectable","3ko0S-5kcaA:7.91"],["3MEK_A_SAMA510_0","SET AND MYND DOMAIN-CONTAINING PROTEIN 3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.18A","3mekA-5kcaA:undetectable","3mekA-5kcaA:18.24"],["3MG0_2_BO221405_1","PROTEASOME COMPONENT PRE3;PROTEASOME COMPONENT PUP1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"THR A 184;ALA A 141;GLY A 440;HIS A 259;SER A 296","None","1.17A","3mg02-5kcaA:undetectable;3mg0V-5kcaA:undetectable","3mg02-5kcaA:14.68;3mg0V-5kcaA:15.66"],["3PS9_A_SAMA670_1","TRNA 5-METHYLAMINOMETHYL-2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"GLY A 144;THR A 126;GLU A 151;ASP A 147","None","1.04A","3ps9A-5kcaA:3.1","3ps9A-5kcaA:21.59"],["3QWP_A_SAMA510_0","SET AND MYND DOMAIN-CONTAINING PROTEIN 3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.19A","3qwpA-5kcaA:undetectable","3qwpA-5kcaA:18.24"],["3SOA_A_DB8A445_1","CALCIUM\/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT ALPHA WITH A BETA 7 LINKER","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"LEU A 671;VAL A 674;MET A 679;PHE A 654","None","1.04A","3soaA-5kcaA:undetectable","3soaA-5kcaA:19.59"],["3U7S_A_017A202_1","POL POLYPROTEIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"LEU A 820;ALA A 533;ASP A 536;ILE A 791;LEU A 819","None","0.99A","3u7sA-5kcaA:undetectable","3u7sA-5kcaA:9.14"],["3UVV_A_T3A501_1","THYROID HORMONE RECEPTOR ALPHA","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ILE A 747;ILE A 717;LEU A 671;ILE A 664;PHE A 654","None","1.08A","3uvvA-5kcaA:undetectable","3uvvA-5kcaA:15.29"],["4AWU_A_4CHA502_0","OXIDOREDUCTASE, FMN-BINDING","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"THR A 103;ASN A 134;LEU A 133;PHE A 185","None","1.38A","4awuA-5kcaA:undetectable","4awuA-5kcaA:17.55"],["4AWU_A_4CHA502_0","OXIDOREDUCTASE, FMN-BINDING","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"THR A 245;ASN A 276;LEU A 275;PHE A 327","None","1.37A","4awuA-5kcaA:undetectable","4awuA-5kcaA:17.55"],["4DRJ_A_RAPA201_2","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4;SERINE\/THREONINE-PROTEIN KINASE MTOR","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"SER A 186;PHE A 185;THR A 103;PHE A 188","None","1.02A","4drjB-5kcaA:undetectable","4drjB-5kcaA:8.58"],["4DRJ_A_RAPA201_2","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4;SERINE\/THREONINE-PROTEIN KINASE MTOR","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"SER A 328;PHE A 327;THR A 245;PHE A 330","None","1.03A","4drjB-5kcaA:undetectable","4drjB-5kcaA:8.58"],["4DRJ_A_RAPA201_2","PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP4;SERINE\/THREONINE-PROTEIN KINASE MTOR","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"SER A 470;PHE A 469;THR A 387;PHE A 472","None","1.06A","4drjB-5kcaA:undetectable","4drjB-5kcaA:8.58"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"PHE A 114;ALA A 167;ALA A 106;PRO A 107","None","1.04A","4dtzB-5kcaA:undetectable","4dtzB-5kcaA:18.55"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"PHE A 256;ALA A 309;ALA A 248;PRO A 249","None","1.05A","4dtzB-5kcaA:undetectable","4dtzB-5kcaA:18.55"],["4ENH_A_FVXA602_1","CHOLESTEROL 24-HYDROXYLASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"LEU A 455;ILE A 368;ILE A 411;ALA A 427;GLY A 440","None","1.10A","4enhA-5kcaA:undetectable","4enhA-5kcaA:18.73"],["4FEX_B_KANB301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASP A 289;ASP A 287;GLU A 151;ASP A 431","None","1.19A","4fexB-5kcaA:undetectable","4fexB-5kcaA:15.36"],["4GKH_B_KANB301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASP A 289;ASP A 287;GLU A 151;ASP A 431","None","1.17A","4gkhB-5kcaA:undetectable","4gkhB-5kcaA:15.36"],["4GKI_C_KANC301_1","AMINOGLYCOSIDE 3'-PHOSPHOTRANSFERASE APHA1-IAB","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASP A 289;ASP A 287;GLU A 151;ASP A 431","None","1.20A","4gkiC-5kcaA:undetectable","4gkiC-5kcaA:15.36"],["4N09_C_ADNC401_2","ADENOSINE KINASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASN A 822;LEU A 819;SER A 865;ASN A 881","None","1.30A","4n09C-5kcaA:undetectable","4n09C-5kcaA:16.74"],["4POO_B_SAMB301_0","PUTATIVE RNA METHYLASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"THR A 629;GLY A 877;ASN A 876;HIS A 602;SER A 581","None","1.22A","4pooB-5kcaA:2.7","4pooB-5kcaA:14.94"],["4QVN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 259;SER A 296;THR A 184;ALA A 141;GLY A 440","None","1.19A","4qvnV-5kcaA:undetectable;4qvnb-5kcaA:undetectable","4qvnV-5kcaA:14.24;4qvnb-5kcaA:14.68"],["4QVN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 401;SER A 438;THR A 326;ALA A 283;GLY A 156","None","1.16A","4qvnV-5kcaA:undetectable;4qvnb-5kcaA:undetectable","4qvnV-5kcaA:14.24;4qvnb-5kcaA:14.68"],["4QVN_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 259;SER A 296;THR A 184;ALA A 141;GLY A 440","None","1.18A","4qvnH-5kcaA:undetectable;4qvnN-5kcaA:undetectable","4qvnH-5kcaA:14.24;4qvnN-5kcaA:14.68"],["4QVN_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 401;SER A 438;THR A 326;ALA A 283;GLY A 156","None","1.15A","4qvnH-5kcaA:undetectable;4qvnN-5kcaA:undetectable","4qvnH-5kcaA:14.24;4qvnN-5kcaA:14.68"],["4XJE_A_TOYA202_1","AADB","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASP A 145;GLU A 547;ILE A 512;TYR A 324","None","1.03A","4xjeA-5kcaA:undetectable","4xjeA-5kcaA:11.96"],["5AXD_A_RBVA502_2","ADENOSYLHOMOCYSTEINASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",3,"THR A 212;HIS A 599;LEU A 839","None","0.57A","5axdA-5kcaA:4.1","5axdA-5kcaA:18.86"],["5CCM_A_SAMA504_0","HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.22A","5ccmA-5kcaA:undetectable","5ccmA-5kcaA:18.20"],["5CFS_A_TOYA203_1","AAD(2''),GENTAMICIN 2''-NUCLEOTIDYLTRANSFERASE,GENTAMICIN RESISTANCE PROTEIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ASP A 145;GLU A 547;ILE A 512;TYR A 324","None","0.96A","5cfsA-5kcaA:undetectable","5cfsA-5kcaA:11.96"],["5FQD_E_LVYE1438_1","PROTEIN CEREBLON;CASEIN KINASE I ISOFORM ALPHA","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ASN A 115;HIS A 117;SER A 183;PHE A  86;ILE A 139","None","1.43A","5fqdE-5kcaA:undetectable;5fqdF-5kcaA:undetectable","5fqdE-5kcaA:18.16;5fqdF-5kcaA:16.40"],["5NFP_A_8W5A804_2","GLUCOCORTICOID RECEPTOR","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"LEU A 630;MET A 855;ILE A 605;LEU A 820","None","1.41A","5nfpA-5kcaA:undetectable","5nfpA-5kcaA:14.82"],["5PBE_A_TYLA2001_1","BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"VAL A 261;TYR A 324;ASN A 213;ILE A 512","None","0.93A","5pbeA-5kcaA:undetectable","5pbeA-5kcaA:9.88"],["5UPD_A_SAMA1301_0","HISTONE-LYSINE N-METHYLTRANSFERASE NSD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 540;TYR A 814;LEU A 818","None","1.44A","5updA-5kcaA:undetectable","5updA-5kcaA:12.91"],["5V37_A_SAMA504_0","HISTONE-LYSINE N-METHYLTRANSFERASE SMYD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.43A","5v37A-5kcaA:undetectable","5v37A-5kcaA:18.20"],["5VKQ_A_PCFA1801_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ILE A 745;ILE A 664;LEU A 671;PHE A 670","None","1.00A","5vkqA-5kcaA:undetectable;5vkqB-5kcaA:undetectable","5vkqA-5kcaA:19.13;5vkqB-5kcaA:19.13"],["5VKQ_D_PCFD1807_0","NO MECHANORECEPTOR POTENTIAL C ISOFORM L","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ILE A 745;ILE A 664;LEU A 671;PHE A 670","None","0.98A","5vkqA-5kcaA:undetectable;5vkqD-5kcaA:undetectable","5vkqA-5kcaA:19.13;5vkqD-5kcaA:19.13"],["5XXG_A_SAMA502_0","SMYD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.30A","5xxgA-5kcaA:undetectable","5xxgA-5kcaA:18.05"],["5XXJ_A_SAMA505_0","SMYD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 788;ASN A 822;TYR A 814","None","1.20A","5xxjA-5kcaA:undetectable","5xxjA-5kcaA:18.05"],["6CEN_A_SAMA1301_0","HISTONE-LYSINE N-METHYLTRANSFERASE NSD3","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"ARG A 786;GLY A 787;ASN A 540;TYR A 814;LEU A 818","None","1.39A","6cenA-5kcaA:undetectable","6cenA-5kcaA:12.99"],["6CK2_C_IPHC101_0","INSULIN A CHAIN;INSULIN B CHAIN","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"ILE A 813;LEU A 820;HIS A 602;ALA A 578","None","0.86A","6ck2C-5kcaA:undetectable;6ck2D-5kcaA:undetectable","6ck2C-5kcaA:2.58;6ck2D-5kcaA:3.93"],["6EF6_A_ACTA405_0","AMINOGLYCOSIDE PHOSPHOTRANSFERASE","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",4,"PRO A 777;GLN A 782;ARG A 783;ILE A 780","None","1.46A","6ef6A-5kcaA:undetectable","6ef6A-5kcaA:17.82"],["6HWD_B_BO2B201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 259;SER A 296;THR A 184;ALA A 141;GLY A 440","None","1.22A","6hwdV-5kcaA:undetectable;6hwdb-5kcaA:undetectable","6hwdV-5kcaA:9.55;6hwdb-5kcaA:6.91"],["6HWD_B_BO2B201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 401;SER A 438;THR A 326;ALA A 283;GLY A 156","None","1.19A","6hwdV-5kcaA:undetectable;6hwdb-5kcaA:undetectable","6hwdV-5kcaA:9.55;6hwdb-5kcaA:6.91"],["6HWD_N_BO2N201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 259;SER A 296;THR A 184;ALA A 141;GLY A 440","None","1.23A","6hwdH-5kcaA:undetectable;6hwdN-5kcaA:undetectable","6hwdH-5kcaA:9.55;6hwdN-5kcaA:6.91"],["6HWD_N_BO2N201_0","PROTEASOME SUBUNIT BETA TYPE-1;PROTEASOME SUBUNIT BETA TYPE-2","5kca","CEREBELLIN-1,CEREBELLIN-1,CEREBELLIN-1,GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2","Homo sapiens",5,"HIS A 401;SER A 438;THR A 326;ALA A 283;GLY A 156","None","1.20A","6hwdH-5kcaA:undetectable;6hwdN-5kcaA:undetectable","6hwdH-5kcaA:9.55;6hwdN-5kcaA:6.91"]]